99%+ Purity Levobupivacaine Hydrochloride (Levobupivacaine HCL)CAS 27262-48-2
Product Details:
| Levobupivacaine HCL Powder Information | ||
| Levobupivacaine HCL Price | 1kg | According to your needs |
| 25kg | According to your needs | |
| 100kg | According to your needs | |
| Packaging | 1kg/foil bag,25kg/drum | |
| Delivery time | About 7 days | |
| Shipping | EMS, Hongkong Post, DHL, TNT, Fedex and so on. | |
| Payment terms | WU, MG, Bitcoin, T/T | |
| Minimum order | 10g powder | |
99%+ Purity Levobupivacaine Hydrochloride (Levobupivacaine HCL)CAS 27262-48-2
Product Name: Levobupivacaine Hydrochloride
Levobupivacaine Hydrochloride Alias: Levobupivacaine Hcl
Levobupivacaine Hydrochloride CAS: 27262-48-2
Levobupivacaine Hydrochloride MF: C18h29cln2o
Levobupivacaine Hydrochloride MW: 324.89
Appearance: White crystalline Powder
Assay: 99%
Grade: USP standard
Minimum Order Quantity: 10g
Usage:Anesthetic;Na+ channel inhibitor.
Package:1kg/bag;25kg/drum.
Levobupivacaine Hydrochloride Description:
Levobupivacaine Hydrochloride is a local anaesthetic drug belonging to the amino amide group. Levobupivacaine Hydrochloride is the S-enantiomer of bupivacaine.
Levobupivacaine Hydrochloride, an amide derivative with anesthetic property. Levobupivacaine Hydrochloride reversibly binds voltage-gated sodium channels to modulate ionic flux and prevent the initiation and transmission of nerve impulses (stabilizing neuronal membrane), thereby resulting in analgesia and anesthesia. In comparison with racemic bupivacaine, Levobupivacaine Hydrochloride is associated with less vasodilation and has a longer duration of action.
Levobupivacaine Hydrochloride Application:
Indications are mainly used for surgical epidural anesthesia.Adult for nerve block or infiltration anesthesia, a maximum dose of 150mg. Concentration of the preparation of the solution: surgical epidural block: 0.5% ~ 0.75% 10 ~ 20ml 50 ~ 150mg moderate to all motor block.
Levobupivacaine Hydrochloride Adverse Effects:
Adverse drug reactions (ADRs) are rare when it is administered correctly. Most ADRs relate to administration technique (resulting in systemic exposure) or pharmacological effects of anesthesia, however allergic reactions can rarely occur.
Systemic exposure to excessive quantities of bupivacaine mainly result in central nervous system (CNS) and cardiovascular effects – CNS effects usually occur at lower blood plasma concentrations and additional cardiovascular effects present at higher concentrations, though cardiovascular collapse may also occur with low concentrations. CNS effects may include CNS excitation (nervousness, tingling around the mouth, tinnitus, tremor, dizziness, blurred vision, seizures) followed by depression (drowsiness, loss of consciousness, respiratory depression and apnea). Cardiovascular effects include hypotension, bradycardia, arrhythmias, and/or cardiac arrest – some of which may be due to hypoxemia secondary to respiratory depression.
